Stay updated on Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.

Latest updates to the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page
- ChecktodayChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check7 days agoChange DetectedA banner announces an NIH website transition and links to updates and FAQs. The study record remains inaccessible because the page displays a 403 error.SummaryDifference1%

- Check14 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check21 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check42 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the expected content, indicating restricted access to the study details. The page shows a standard error layout, with the study content effectively unavailable.SummaryDifference18%

- Check63 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing the previous v3.6.5. This indicates a new revision of the page content and implies minor updates to the document.SummaryDifference0.1%

Stay in the know with updates to Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat and Pembrolizumab in Advanced Pancreatic Cancer Clinical Trial page.